NRX PHARMACEUTICALS INC (NRXP:NASDAQ)

$2.6 -0.11 (-4.059%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 57

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed NRX PHARMACEUTICALS INC (NRXP:NASDAQ) News Sources

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

25-06-2026

yahoo.com

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

07-08-2026

yahoo.com

NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles

10-08-2026

marketbeat.com

NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates

15-08-2026

yahoo.com

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET

17-08-2026

yahoo.com

NRX Pharmaceuticals Inc (NRXP) (Q2 2026) Earnings Call Highlights: Advancing Ketamine Pipeline ...

18-08-2026

yahoo.com

NRx Pharmaceuticals to Participate in Upcoming Investor Conferences

08-09-2026

yahoo.com

GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)

14-09-2026

yahoo.com

NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine

15-09-2026

yahoo.com

NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine

15-10-2026

yahoo.com

NRX PHARMACEUTICALS INC (NRXP:NASDAQ) Sentiment Trend

0 25 50 75 100 15 59 46 2 64 91 78 85 55 75 25-06-2026 07-08-2026 10-08-2026 15-08-2026 17-08-2026 18-08-2026 08-09-2026 14-09-2026 15-09-2026 15-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

NRX PHARMACEUTICALS INC (NRXP:NASDAQ) FAQs

toggle

What is the current price of NRX PHARMACEUTICALS INC (NRXP:NASDAQ)?

The current price of NRX PHARMACEUTICALS INC (NRXP:NASDAQ) is $2.6.


toggle

NRX PHARMACEUTICALS INC (NRXP:NASDAQ) absolute price change since previous trading day?

The absolute price change of NRX PHARMACEUTICALS INC (NRXP:NASDAQ) since the previous trading day is $-0.11.


toggle

NRX PHARMACEUTICALS INC (NRXP:NASDAQ) percentage price change since previous trading day?

The percentage price change of NRX PHARMACEUTICALS INC (NRXP:NASDAQ) since the previous trading day is -4.059%.


toggle

What is the most recent average sentiment score for NRX PHARMACEUTICALS INC (NRXP:NASDAQ)?

The most recent average sentiment score for NRX PHARMACEUTICALS INC (NRXP:NASDAQ) is 57 out of 100.


toggle

What is the most recent average sentiment for NRX PHARMACEUTICALS INC (NRXP:NASDAQ)?

The most recent sentiment for NRX PHARMACEUTICALS INC (NRXP:NASDAQ) is .


SEC-8K** Filing Available For NRX PHARMACEUTICALS INC (NRXP:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.